Table 3. Viral inactivation solution analytical equivalency study.

There was a 100% agreement with samples positive for SARS-CoV2 (with and without VIS) and a 100% agreement with sample negative for SARS-CoV2 (with and without VIS).

Concentration of positive SARS-CoV2 RNA in saliva	Replicates	No VIS: Mean Ct (SD)			VIS Ct: Mean Ct (SD)			% Agreement
		N1	E	RP	N1	E	RP
2x LoD	10	28.3 (1.3)	28.8 (1.3)	22.6 (0.3)	26.4 (3.3)	27.8 (2.2)	23.3 (0.5)	100%
Negative (no viral RNA added)	10	n.d.	n.d.	22.5 (.2)	n.d.	n.d.	23.6 (0.4)	100%

Notes.

n.d. = not detected, cycle threshold growth curves do not cross the baseline before 40 cycles.

SD

Standard deviation

VIS

Viral inactivating solution